Page last updated: 2024-10-21

4-diphenylacetoxy-1,1-dimethylpiperidinium and Myocardial Ischemia

4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Myocardial Ischemia in 1 studies

4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yue, P1
Lü, YJ1
Yang, BF1

Reviews

1 review available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Myocardial Ischemia

ArticleYear
[Advances in the study of cardiac M3 receptor as a novel target of antiarrhythmic drugs].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2006, Volume: 41, Issue:8

    Topics: Animals; Delayed Rectifier Potassium Channels; Humans; Membrane Potentials; Myocardial Ischemia; Pil

2006